Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV000755940 | SCV000883621 | likely pathogenic | not provided | 2017-08-08 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000755940 | SCV003821294 | pathogenic | not provided | 2022-11-24 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004547947 | SCV004107491 | pathogenic | COL1A1-related disorder | 2023-05-22 | criteria provided, single submitter | clinical testing | The COL1A1 c.2650G>A variant is predicted to result in the amino acid substitution p.Gly884Ser. This variant was reported in an individual with osteogenesis imperfecta type II (Table 2, Bodian et al. 2009. PubMed ID: 18996919). This variant is located in the conserved Gly-Xaa-Yaa triple helical domain where substitutions of a glycine are usually pathogenic (Marini et al. 2007. PubMed ID: 17078022). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. This variant is interpreted as pathogenic. |